当前位置:首页 - 行情中心 - 奥翔药业(603229) - 财务分析

奥翔药业

(603229)

  

流通市值:64.27亿  总市值:64.27亿
流通股本:8.30亿   总股本:8.30亿

奥翔药业(603229)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.97亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益236718.63万元,未分配利润100106.06万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产315683.85万元,负债78965.22万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入308,673,252.77792,759,011.85645,961,585.61481,872,188.3
营业总成本193,930,900.75670,523,160.48436,884,971.86302,198,297.13
其他经营收益
营业利润107,365,877.18140,045,154.4234,233,339.74195,436,252.9
利润总额107,330,659.49137,903,857.48233,345,728.07194,677,453.13
净利润96,662,497.25130,570,123.6207,031,905.94169,346,106.65
每股收益
其他综合收益199,836.82-262,560.7119,962.489,445.84
综合收益总额96,862,334.07130,307,562.89207,051,868.42169,355,552.49
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,878,870,467.461,815,331,179.771,793,706,183.581,861,691,662.7
非流动资产:
非流动资产合计1,277,968,052.61,269,919,485.681,266,647,706.631,273,369,390.87
资产总计3,156,838,520.063,085,250,665.453,060,353,890.213,135,061,053.57
流动负债:
流动负债合计711,085,662.81736,019,871.51631,624,715.86656,893,917.84
非流动负债:
非流动负债合计78,566,579.2779,872,580.3181,428,542.3252,457,685.02
负债合计789,652,242.08815,892,451.82713,053,258.18709,351,602.86
所有者权益(或股东权益):
归属于母公司股东权益合计2,367,186,277.982,269,358,213.632,347,300,632.032,425,709,450.71
股东权益合计2,367,186,277.982,269,358,213.632,347,300,632.032,425,709,450.71
负债和股东权益合计3,156,838,520.063,085,250,665.453,060,353,890.213,135,061,053.57
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计188,380,264.34984,246,886.73720,011,893.88436,663,112.49
经营活动现金流出小计222,415,242.33827,737,972.48572,366,281.51391,259,445.69
经营活动产生的现金流量净额-34,034,977.99156,508,914.25147,645,612.3745,403,666.8
投资活动产生的现金流量:
投资活动现金流入小计8,887,293.0867,034,020.9748,088,170.7739,477,425.08
投资活动现金流出小计30,180,011.68125,457,198.3395,925,955.1767,801,763.71
投资活动产生的现金流量净额-21,292,718.6-58,423,177.36-47,837,784.4-28,324,338.63
筹资活动产生的现金流量:
筹资活动现金流入小计101,602,116.48524,517,726.44307,896,522.55246,589,792.79
筹资活动现金流出小计93,972,034.93474,066,371.82373,013,518.93242,733,760.37
筹资活动产生的现金流量净额7,630,081.5550,451,354.62-65,116,996.383,856,032.42
汇率变动对现金及现金等价物的影响-22,048,408.04-17,457,141.89-2,547,447.625,776,044.16
现金及现金等价物净增加额-69,746,023.08131,079,949.6232,143,383.9726,711,404.75
期末现金及现金等价物余额1,109,915,145.691,179,661,168.771,080,724,603.121,075,292,623.9
补充资料:
现金及现金等价物的净增加额-131,079,949.62-26,711,404.75
最新报告期:2026-05-05
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
招商证券侯彪,梁广楷,许菲菲0.180.220.272026-05-05
TOP↑